Insider Transactions in Q2 2024 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
231,548
-100.0%
|
$0
$0.95 P/Share
|
|
Jun 06
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
118,452
-33.83%
|
$0
$0.98 P/Share
|
|
Jun 05
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
468,044
-57.21%
|
$0
$0.96 P/Share
|
|
Jun 04
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,592
-0.31%
|
$0
$0.99 P/Share
|
|
Jun 04
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
652
-0.16%
|
$0
$0.99 P/Share
|
|
Jun 04
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
341,040
-29.42%
|
$0
$0.95 P/Share
|
|
Jun 03
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
360,744
-23.73%
|
$360,744
$1.0 P/Share
|
|
May 31
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
204,394
-11.85%
|
$0
$0.95 P/Share
|
|
May 06
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,576
-0.31%
|
$3,576
$1.13 P/Share
|
|
Apr 22
2024
|
Reshma Rangwala EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,789
-1.94%
|
$6,789
$1.17 P/Share
|
|
Apr 04
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,563
-0.31%
|
$3,563
$1.29 P/Share
|